Literature DB >> 188859

Adriamycin therapy for advanced insulinoma.

R C Eastman, S E Come, G J Strewler, P Gorden, C R Kahn.   

Abstract

Two patients with advanced metastatic insulinoma are presented. Both failed to respond to streptozotocin and were refractory to other forms of chemotherapy. Therapy with adriamycin (Patient No. 1) and adriamycin plus 5-fluorouracil (Patient No. 2) led to significant decreases in insulin levels or measurable disease and both patients had clinical remissions lasting 5 to 7 months. Adriamycin may be effective in patients with advanced insulinoma unresponsive to conventional chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 188859     DOI: 10.1210/jcem-44-1-142

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

1.  Malignant insulinoma--a case report.

Authors:  J Geoghegan; C O'Keane; D Powell; F X O'Connell
Journal:  Ir J Med Sci       Date:  1987-07       Impact factor: 1.568

Review 2.  [Islet cell cancer with organic hyperinsulinism. Clinical aspects, diagnosis and therapy].

Authors:  R Wirsching; F Spelsberg; R Landgraf
Journal:  Klin Wochenschr       Date:  1982-08-16

3.  Zollinger-Ellison Syndrome.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.